Literature DB >> 11175794

Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele.

G Morahan1, D Huang, S I Ymer, M R Cancilla, K Stephen, P Dabadghao, G Werther, B D Tait, L C Harrison, P G Colman.   

Abstract

Type 1 diabetes (T1D; or insulin-dependent diabetes mellitus, IDDM) is an autoimmune disease with both genetic and environmental components. In addition to the human leukocyte antigen (HLA) complex, the single major genetic contributor of susceptibility, an unknown number of other unidentified genes are required to mediate disease. Although many loci conferring susceptibility to T1D have been mapped, their identification has proven problematic due to the complex nature of this disease. Our strategy for finding T1D susceptibility genes has been to test for human homologues of loci implicated in diabetes-prone NOD (non-obese diabetic) mice, together with application of biologically relevant stratification methods. We report here a new susceptibility locus, IDDM18, located near the interleukin-12 (IL-12)p40 gene, IL12B. Significant bias in transmission of IL12B alleles was observed in affected sibpairs and was confirmed in an independent cohort of simplex families. A single base change in the 3' UTR showed strong linkage disequilibrium with the T1D susceptibility locus. The IL12B 3' UTR alleles showed different levels of expression in cell lines. Variation in IL-12p40 production may influence T-cell responses crucial for either mediating or protecting against this and other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175794     DOI: 10.1038/84872

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  71 in total

Review 1.  Science, medicine, and the future: Postgenomic technologies: hunting the genes for common disorders.

Authors:  C Mathew
Journal:  BMJ       Date:  2001-04-28

2.  Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway.

Authors:  T S Kim; B Y Kang; M H Lee; Y K Choe; S Y Hwang
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

3.  Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease.

Authors:  Muddassar M Mirza; Sheila A Fisher; Kathy King; Andrew P Cuthbert; Jochen Hampe; Jeremy Sanderson; John Mansfield; Peter Donaldson; Andrew J S Macpherson; Alastair Forbes; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Am J Hum Genet       Date:  2003-03-03       Impact factor: 11.025

Review 4.  Toxic type 1 diabetes.

Authors:  Mark A Myers; Ian R Mackay; Paul Z Zimmet
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

5.  New autoimmune genes and the pathogenesis of type 1 diabetes.

Authors:  Lars Hornum; Helle Markholst
Journal:  Curr Diab Rep       Date:  2004-04       Impact factor: 4.810

Review 6.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

7.  Association of interferon gamma T+874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates.

Authors:  G Bokodi; L Derzbach; I Bányász; T Tulassay; B Vásárhelyi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-06-05       Impact factor: 5.747

8.  Effect of linkage status of affected sib-pairs on the search for novel type 1 diabetes susceptibility genes in the HLA complex.

Authors:  G Morahan; M Mehta; E McKinnon; I James
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.

Authors:  G Morahan; E McKinnon; J Berry; B Browning; C Julier; F Pociot; I James
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

10.  The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Authors:  C Julier; B Akolkar; P Concannon; G Morahan; C Nierras; A Pugliese
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.